Cerenia (maropitant citrate) Injectable Solution
is indicated for the prevention and treatment of acute vomiting in dogs and cats. Maropitant citrate acts by blocking vomiting signals to the brain to prevent vomiting.
Dosage and Administration: Administer
CERENIA Injectable Solution subcutaneously at 1.0 mg/kg (0.45 mg/lb)
equal to 1.0 mL/10 kg (1.0 mL/22 lb) of body weight once daily for up to
5 consecutive days.
For subcutaneous injection in dogs and cats only
CERENIA Injectable Solution is recommended for
use in dogs and cats 16 weeks and older.
CERENIA Injectable Solution may be used
interchangeably with CERENIA Tablets for once daily dosing for the
prevention of acute vomiting.
Warnings: Not for use in humans. Keep out
of reach of children. In case of accidental injection or exposure, seek
medical advice. Topical exposure may elicit localized allergic skin
reactions in some individuals. Repeated or prolonged exposure may lead
to skin sensitization. In case of accidental skin exposure, wash with
soap and water. CERENIA is also an ocular irritant. In case of
accidental eye exposure, flush with water for 15 minutes and seek
In puppies younger than 11 weeks of age,
histological evidence of bone marrow hypoplasia was seen at higher
frequency and greater severity in puppies treated with CERENIA than in
control puppies. In puppies 16 weeks and older, bone marrow hypoplasia
was not seen (See Animal Safety Section).
Precautions: For subcutaneous injection
only. The safe use of CERENIA has not been evaluated in dogs used for
breeding, pregnant or lactating bitches, dogs with gastrointestinal
obstruction, or dogs that have ingested toxins. Use with caution in dogs
with hepatic dysfunction. Use with caution with other medications that
are highly protein bound. The concomitant use of CERENIA with other
protein bound drugs has not been studied in dogs. Commonly used protein
bound drugs include NSAIDs, cardiac, anticonvulsant and behavioral
medications. The influence of concomitant drugs that may inhibit
metabolism of CERENIA has not been evaluated. Drug compatibility should
be monitored in patients requiring adjunctive therapy.Federal (USA) law restricts this
drug to use by or on the order of a licensed veterinarian
Pfizer Animal Health